Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Moodys
Cipla
Deloitte
Chubb
Colorcon

Generated: July 22, 2019

DrugPatentWatch Database Preview

Rituximab - Biologic Drug Details

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for rituximab
Tradenames:1
Patents:698
Applicants:1
BLAs:1
Suppliers: see list1
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for rituximab
Pharmacology for rituximab

US Patents for rituximab

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26 ➤ Try a Free Trial SAMSUNG LIFE PUBLIC WELFARE FOUNDATION (Seoul, KR) ➤ Try a Free Trial RX search
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26 ➤ Try a Free Trial Pharmacyclics LLC (Sunnyvale, CA) ➤ Try a Free Trial RX search
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26 ➤ Try a Free Trial Array BioPharma Inc. (Boulder, CO) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for rituximab

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
642 Luxembourg ➤ Try a Free Trial PRODUCT NAME: POMALIDOMIDE ET SES SELS, SOLVATES, HYDRATES OU STEREOISOMERES PHARMACEUTIQUEMENT ACCEPTABLES QUI EN DERIVENT (IMNOVID); FIRST REGISTRATION DATE: 20130805
0903 Netherlands ➤ Try a Free Trial PRODUCT NAME: INOTUZUMAB OZOGAMICIN; REGISTRATION NO/DATE: EU/1/17/1200 20170703
2015 Austria ➤ Try a Free Trial PRODUCT NAME: POMALIDOMID UND SEINE PHARMAZEUTISCH AKZEPTABLEN SALZE, SOLVATE, HYDRATE ODER STEREOISOMERE; REGISTRATION NO/DATE: EU/1/13/850 20130805
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Chinese Patent Office
Colorcon
Cantor Fitzgerald
Boehringer Ingelheim
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.